Literature DB >> 25486926

Breakpoint heterogeneity in (2;3)(p15-23;q26) translocations involving EVI1 in myeloid hemopathies.

Marc De Braekeleer1, Nadia Guéganic2, Corine Tous3, Marie-Josée Le Bris3, Audrey Basinko4, Frédéric Morel5, Nathalie Douet-Guilbert5.   

Abstract

Several chromosomal rearrangements involving band 3q26 are known to induce EVI1 overexpression. They include inv(3)(q21q26), t(3;3)(q21;q26), t(3;21)(q26;q22) and t(3;12)(q26;p13). Translocations involving the short arm of chromosome 2 and 3q26 have been reported in more than 50 patients with myeloid disorders. However, although the breakpoints on 2p are scattered over a long segment, their distribution had only been analyzed in 9 patients. We performed fluorescent in situ hybridization with a library of BAC (Bacterial Artificial Chromosome) clones in 4 patients with t(2;3)(p15-23;q26). Our results combined with those of the 9 previously reported patients showed scattering of the breakpoints in 2 regions. A 1.08Mb region in band 2p21 encompassing the MTA3, ZFP36L2 and THADA genes was documented in 5 patients. A second region of 1.83Mb in band 2p16.1 was identified in 8 patients. Four patients showed clustering around the BCL11A gene and the remaining 4 around a long intergenic non-coding RNA, FLJ30838. These regions are characterized by the presence of regulatory sequences (CpG islands and promoters) that could be instrumental in EVI1 overexpression.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breakpoint distribution; Chromosomal translocation; Chromosome 2; EVI1; Myeloid hemopathies

Mesh:

Substances:

Year:  2014        PMID: 25486926     DOI: 10.1016/j.bcmd.2014.11.015

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  2 in total

1.  Relationship Between P15 Gene Mutation and Formation and Metastasis of Malignant Osteosarcoma.

Authors:  ChangShui Yu; WenBo Wang
Journal:  Med Sci Monit       Date:  2016-02-27

2.  Data on MECOM rearrangement-driven chromosomal aberrations in myeloid malignancies.

Authors:  Zhenya Tang; Guilin Tang; Shimin Hu; Keyur P Patel; C Cameron Yin; Wei Wang; Pei Lin; Gokce A Toruner; Chi Y Ok; Jun Gu; Xinyan Lu; Joseph D Khoury; L Jeffrey Medeiros
Journal:  Data Brief       Date:  2019-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.